You are here

ESCs/iPSCs

A New Strategy to Efficiently Identify Cells Undergoing Reprogramming

Selecting cells with high inherent reprogramming potential via CAG promoter activity represents a possible means to improve reprogramming efficiency

Early Detection of Phenotypes in GD1 Neurons

Synthetic mRNA‐induced differentiation may accelerate our understanding of Parkinson's disease development in GD1 patients

iPSC Models of Glial Dysfunction

A new review summarizes advances in iPSC‐based modeling to explore glial cell involvement in neurodegenerative diseases

Disease-specific iPSC Model Highlights New Therapeutic Avenue for Vision Loss

iPSC-derived AMD model used to investigate the interplay between lysosome function and complement activation in the hope of identifying therapeutic targets

Deciphering the MicroRNA-mediated Control of Pluripotent Stem Cell Differentiation

The miR‐183/96/182 cluster controls retinal tissue morphogenesis and represents an important regulator of PAX6 expression

Boosting Cardiac Differentiation of ESCs via miR‐184/Wnt3 Pathway Modulation

Modulating the miR‐184/Wnt3 pathway in embryonic stem cells may provide for the development of efficient cell therapies for the damaged heart

The Mediator Complex – The Gateway to Naïve Pluripotency?

CDK8/19 Mediator components control pluripotent stem cell differentiation and self-renewal and regulate preimplantation naïve epiblast gene expression

Induction of Alveolar Type I Cells from iPSCs

Kanagaki et al. underscore the potential utility of iPSC-derived AT1cells in understanding their differentiation from AT2 cells in vitro.

Modeling Aortic Diseases Using iPSCs

A review summarizes in vitro models used in aortic disease research and provides guidance for the development of advanced models using iPSCs

Chromatin Accessibility in Canine Reprogramming

New research identifies differences in the global chromatin landscape that occur during the cellular reprogramming of canine cells

Pages

Subscribe to RSS - ESCs/iPSCs